Page last updated: 2024-09-04

resiquimod and Genital Herpes

resiquimod has been researched along with Genital Herpes in 11 studies

Research

Studies (11)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	11 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Huang, DB; Tyring, SK; Wu, JJ	1
Cartier, JL; Davis, HL; McCluskie, MJ; Patrick, AJ; Rosenthal, KL; Sajic, D; Weeratna, RD	1
Bergland, VA; Corey, L; Huang, ML; Leone, P; Magaret, AS; Mark, KE; Meng, TC; Sacks, SL; Selke, S; Slade, HB; Tyring, SK; Wald, A; Warren, T	1
Ferris, DG; Fife, KH; Liu, P; Meng, TC	1
Ashkar, AA; Davies, EJ; Gill, N	1
Bernstein, DI; Harrison, CJ; Miller, RL; Tomai, MA	2
McConnell, J	1
Stephenson, J	1
Meng, TC; Smith, MH; Spruance, SL; Tyring, SK	1

Reviews

3 review(s) available for resiquimod and Genital Herpes

Article	Year
Resiquimod: a new immune response modifier with potential as a vaccine adjuvant for Th1 immune responses. Antiviral research, 2004, Volume: 64, Issue:2 Topics: Adjuvants, Immunologic; Adult; Animals; Guinea Pigs; Herpes Genitalis; Herpesvirus 2, Human; Humans; Imidazoles; Th1 Cells; Viral Vaccines	2004
The role of toll-like receptor ligands/agonists in protection against genital HSV-2 infection. American journal of reproductive immunology (New York, N.Y. : 1989), 2008, Volume: 59, Issue:1 Topics: Adjuvants, Immunologic; Aminoquinolines; Antiviral Agents; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Imidazoles; Imiquimod; Immunity, Innate; Ligands; Lipopolysaccharides; Mucous Membrane; Poly I-C; Toll-Like Receptors; Vagina	2008
Immunomodulation as a treatment strategy for genital herpes: review of the evidence. International immunopharmacology, 2002, Volume: 2, Issue:4 Topics: Adjuvants, Immunologic; Aminoquinolines; Animals; Herpes Genitalis; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Imidazoles; Imiquimod; Recurrence	2002

Trials

4 trial(s) available for resiquimod and Genital Herpes

Article	Year
Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial. The Journal of infectious diseases, 2007, May-01, Volume: 195, Issue:9 Topics: Administration, Cutaneous; Adolescent; Adult; Aged; Antiviral Agents; Disease-Free Survival; DNA, Viral; Double-Blind Method; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Imidazoles; Male; Middle Aged; Polymerase Chain Reaction; Recurrence; Treatment Outcome; Virus Shedding	2007
Effect of resiquimod 0.01% gel on lesion healing and viral shedding when applied to genital herpes lesions. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:2 Topics: Administration, Topical; Adult; Aged; Antiviral Agents; Double-Blind Method; Female; Herpes Genitalis; Herpesvirus 2, Human; Humans; Imidazoles; Male; Middle Aged; Proportional Hazards Models; Time Factors; Treatment Outcome; Virus Shedding; Wound Healing	2008
New hope for genital herpes treatment. Lancet (London, England), 2001, Apr-14, Volume: 357, Issue:9263 Topics: Adult; Herpes Genitalis; Humans; Imidazoles	2001
Application of a topical immune response modifier, resiquimod gel, to modify the recurrence rate of recurrent genital herpes: a pilot study. The Journal of infectious diseases, 2001, Jul-15, Volume: 184, Issue:2 Topics: Adult; Double-Blind Method; Female; Gels; Herpes Genitalis; Humans; Imidazoles; Immunologic Factors; Male; Middle Aged; Pilot Projects; Proportional Hazards Models; Secondary Prevention; Treatment Outcome	2001

Other Studies

4 other study(ies) available for resiquimod and Genital Herpes

Article	Year
Treatment of intravaginal HSV-2 infection in mice: a comparison of CpG oligodeoxynucleotides and resiquimod (R-848). Antiviral research, 2006, Volume: 69, Issue:2 Topics: Adjuvants, Immunologic; Animals; CpG Islands; Female; Herpes Genitalis; Herpesvirus 2, Human; Imidazoles; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Oligodeoxyribonucleotides; Treatment Outcome; Vagina	2006
Daily or weekly therapy with resiquimod (R-848) reduces genital recurrences in herpes simplex virus-infected guinea pigs during and after treatment. The Journal of infectious diseases, 2001, Mar-15, Volume: 183, Issue:6 Topics: Animals; Antibodies, Viral; Antigens, Viral; Cells, Cultured; Drug Administration Schedule; Drug Evaluation, Preclinical; Female; Guinea Pigs; Herpes Genitalis; Herpesvirus 2, Human; Imidazoles; Immunologic Factors; Interferons; Interleukin-2; Leukocytes, Mononuclear; Random Allocation; Secondary Prevention; Time Factors	2001
New therapy promising for genital herpes. JAMA, 2001, May-02, Volume: 285, Issue:17 Topics: Adjuvants, Immunologic; Antiviral Agents; Clinical Trials as Topic; Drugs, Investigational; Herpes Genitalis; Humans; Imidazoles	2001
Herpes gel research continues. AIDS patient care and STDs, 2001, Volume: 15, Issue:12 Topics: Gels; Herpes Genitalis; Humans; Imidazoles; Immunologic Factors; Research	2001